Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on EGFR Exon 20 Insertion Mutations in NSCLC: Optimising Patient Diagnosis and Management
- Start date
- 05 Dec 2022
- End date
- 06 Dec 2022
- Location
- Singapore, Republic of Singapore
Learning objectives
- To understand the function and biology of EGFR and exon 20 insertion mutations in normal and malignant lung epithelial cells
- To gain insights in the spectrum of atypical EGFR molecular aberrations, platforms and strategies for molecular testing
- To provide information and in-depth discussion on the state-of-the-art and emerging therapeutic strategies integrating EGFR exon 20 insertion mutation inhibition in non-small-cell lung cancer
- To present novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of EGFR exon 20 mutation inhibition
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Sanjay Popat, United Kingdom
- Ross A. Soo, Singapore
Supported by
